HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Truist Financial Corp

Truist Financial Corp raised its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 307,753 shares of the company’s stock after purchasing an additional 7,890 shares during the period. Truist Financial Corp owned about 0.12% of HCA Healthcare worth $92,372,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in HCA. Waldron Private Wealth LLC raised its position in HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after acquiring an additional 29 shares in the last quarter. Integrated Advisors Network LLC lifted its holdings in shares of HCA Healthcare by 0.6% during the third quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after purchasing an additional 31 shares during the last quarter. BayBridge Capital Group LLC raised its holdings in HCA Healthcare by 1.0% during the 3rd quarter. BayBridge Capital Group LLC now owns 3,485 shares of the company’s stock worth $1,416,000 after buying an additional 35 shares during the period. First Horizon Advisors Inc. boosted its holdings in shares of HCA Healthcare by 2.4% in the third quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock worth $623,000 after buying an additional 36 shares during the period. Finally, Mediolanum International Funds Ltd lifted its position in shares of HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after acquiring an additional 36 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $316.18 on Tuesday. The firm has a market capitalization of $80.09 billion, a PE ratio of 14.39, a PEG ratio of 1.11 and a beta of 1.64. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm’s fifty day simple moving average is $313.23 and its 200 day simple moving average is $352.11. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company earned $5.90 earnings per share. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.91%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is currently 12.02%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on HCA shares. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Oppenheimer lifted their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Royal Bank of Canada lowered their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.